Mostrar el registro sencillo del ítem

dc.contributor.authorBarrios-López, Jose María
dc.contributor.authorTriviño-Ibañez, Eva María
dc.contributor.authorPiñeiro-Donis, Adrian
dc.contributor.authorSegovia-Román, Fermin 
dc.contributor.authorPérez García, Maria del Carmen
dc.contributor.authorMarín-Romero, Bartolomé
dc.contributor.authorRomero Villarrubia, Ana
dc.contributor.authorGuillén Martínez, Virginia
dc.contributor.authorMartinez-Barbero, José Pablo
dc.contributor.authorPIñar Morales, Raquel 
dc.contributor.authorBarrero Hernández, Francisco Javier 
dc.contributor.authorMinguez-Castellanos, Adolfo
dc.contributor.authorGómez-Rio, Manuel
dc.date.accessioned2025-11-03T11:18:58Z
dc.date.available2025-11-03T11:18:58Z
dc.date.issued2025-11-01
dc.identifier.citationBarrios-López, J.M.; Triviño-Ibáñez, E.M.; Piñeiro-Donis, A.; Segovia-Román, F.; Pérez García, M.d.C.; Marín-Romero, B.; Romero Villarrubia, A.; Guillén Martínez, V.; Martínez-Barbero, J.P.; Piñar Morales, R.; et al. Baseline Findings from Dual-Phase Amyloid PET Study in Newly Diagnosed Multiple Sclerosis: Exploring Its Potential as a Biomarker of Myelination and Neurodegeneration. J. Pers. Med. 2025, 15, 520. https://doi.org/10.3390/jpm15110520es_ES
dc.identifier.urihttps://hdl.handle.net/10481/107702
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleBaseline Findings from Dual-Phase Amyloid PET Study in Newly Diagnosed Multiple Sclerosis: Exploring Its Potential as a Biomarker of Myelination and Neurodegenerationes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/jpm15110520
dc.type.hasVersionAMes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional